Page last updated: 2024-10-31

1-(3-trifluoromethylphenyl)piperazine and Sleep Initiation and Maintenance Disorders

1-(3-trifluoromethylphenyl)piperazine has been researched along with Sleep Initiation and Maintenance Disorders in 1 studies

1-(3-trifluoromethylphenyl)piperazine: acts as serotonin agonist; structure
1-(3-(trifluoromethyl)phenyl)piperazine : A N-arylpiperazine that is piperazine substituted by a 3-(trifluoromethyl)phenyl group at position 1. A serotonergic agonist used as a recreational drug.

Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.

Research Excerpts

ExcerptRelevanceReference
"The objective of this study was to determine the clinical effects of party pills containing benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) when taken alone and in combination with alcohol."2.75Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol. ( Aldington, S; Beasley, R; Caldwell, B; Dickson, S; Lucas, N; McDowall, J; Robinson, G; Thompson, I; Weatherall, M; Williams, G, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thompson, I1
Williams, G1
Caldwell, B1
Aldington, S1
Dickson, S1
Lucas, N1
McDowall, J1
Weatherall, M1
Robinson, G1
Beasley, R1

Trials

1 trial available for 1-(3-trifluoromethylphenyl)piperazine and Sleep Initiation and Maintenance Disorders

ArticleYear
Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:9

    Topics: Adult; Akathisia, Drug-Induced; Alcohol Drinking; Anxiety; Central Nervous System Stimulants; Cross-

2010